0001144204-18-054178.txt : 20181017
0001144204-18-054178.hdr.sgml : 20181017
20181017142354
ACCESSION NUMBER: 0001144204-18-054178
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181017
FILED AS OF DATE: 20181017
DATE AS OF CHANGE: 20181017
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hayward James A
CENTRAL INDEX KEY: 0001357784
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36745
FILM NUMBER: 181126164
MAIL ADDRESS:
STREET 1: C/O 25 HEALTH SCIENCES DRIVE
STREET 2: SUITE 113
CITY: NEW YORK
STATE: NY
ZIP: 11790
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: APPLIED DNA SCIENCES INC
CENTRAL INDEX KEY: 0000744452
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISCELLANEOUS BUSINESS SERVICES [7380]
IRS NUMBER: 592262718
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 50 HEALTH SCIENCES DRIVE
CITY: STONY BROOK
STATE: NY
ZIP: 11790
BUSINESS PHONE: 631-240-8800
MAIL ADDRESS:
STREET 1: 50 HEALTH SCIENCES DRIVE
CITY: STONY BROOK
STATE: NY
ZIP: 11790
FORMER COMPANY:
FORMER CONFORMED NAME: PROHEALTH MEDICAL TECHNOLOGIES INC
DATE OF NAME CHANGE: 20010504
FORMER COMPANY:
FORMER CONFORMED NAME: DCC ACQUISITION CORP
DATE OF NAME CHANGE: 19990211
FORMER COMPANY:
FORMER CONFORMED NAME: DATALINK CAPITAL CORP/TX/
DATE OF NAME CHANGE: 19980306
4
1
tv504854_4.xml
FORM 4
X0306
4
2018-10-17
0
0000744452
APPLIED DNA SCIENCES INC
APDN
0001357784
Hayward James A
50 HEALTH SCIENCES DRIVE
STONY BROOK
NY
11790
1
1
1
0
Chairman, CEO and President
Stock Option (right to buy)
5.82
2018-10-17
4
D
0
833334
0
D
2018-10-17
Common Stock
833334
0
D
Stock Option (right to buy)
5.82
2018-10-17
4
A
0
833334
0
A
2018-10-17
2023-10-17
Common Stock
833334
833334
D
The two reported transactions involve an amendment of an outstanding option to extend the expiration date of such option from October 17, 2018 to October 17, 2023, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on October 17, 2013 and provided for vesting (i) with respect to 25% of the underlying shares on the anniversary of the original date of grant and (ii) with respect to the remaining underlying shares, ratably each anniversary thereafter until fully vested on the fourth anniversary of the original date of grant.
/s/ Beth Jantzen, Attorney-in-Fact
2018-10-17